TECHNOLOGY FOCUS - ELECTRONICS - Preferred Device: The organic electroluminescent device, particularly as an organic electroluminescent display comprises a compound having the electroluminescent peak with wavelength of not greater than 500 nm, or a compound having the electroluminescent peak with wavelength of not less than 560 nm. The organic layer comprises a charge generating layer as well as the electroluminescent layer. In the organic electroluminescent device, where a mixed region of reductive dopant and organic substance, or a mixed region of oxidative dopant and organic substance is placed on the inner surface of one or both electrode(s) among the pair of electrodes.    TECHNOLOGY FOCUS - INORGANIC CHEMISTRY - Preferred Components: The metal is selected from organic metals of Group 1, Group 2, 4th period and 5th period transition metals, lanthanide metals and d-transition elements from the Periodic Table of Elements.    TECHNOLOGY FOCUS - ORGANIC CHEMISTRY - Preparation (disclosed): Preparation of the compound (I) involves: reduction of anthraquinone compound of formula (iia) to corresponding alcohol compound followed by dehydration and coupling with cyclic amines of formula (iib) and (iic). Preferred Layer: The organic layer comprises at least one compound(s) selected from arylamine compounds and styrylarylamine compounds; and at least one metal. Preferred Definitions:    ring A'and ring B'=piperidin-1-yl, 3,4-dihydro-2H-quinolin-1-yl, 9H-acridin-10-yl, phenothiazin-10-yl, phenoxazin-10-yl, 10-methyl-10H-phenazin-5-yl, 9,9-dimethyl-9H-acridin-10-yl, 2-(10H-spiro(acridine-9,1'-cyclopentane)-10-yl), 10,10-dimethyl-10H-phenazasilin-5-yl, carbazol-9-yl, 10,11-dihydro-dibenzo(b,f)azepin-5-yl, dibenzo(b,f)azepin-5-yl, 2-(5H-spiro(dibenzo(b,e)(1,4)azasiline-10,1'-silolane)-5-yl), 10-phenyl-10H-phenazin-5-yl, 10-naphthalen-1-yl-10H-phenazin-5-yl, 2-(1,3-dihydro-5'H-spiro(benzo(c)silole-2,10'-dibenzo(b,e)(1,4)azasiline)-5'-yl) or 2-(1',3'-dihydro-10H-spiro(acridine-9,2'-indene)-10-yl).    SPECIFIC COMPOUNDS - 1743 Compounds are disclosed as the compounds (I), e.g. 5,5'-(9,10-di(naphthalen-2-yl)anthracene-2,6-diyl)bis(10,11-dihydro-5H-dibenzo(b,f)azepine) (IA), 1,1'-(9,10-dimethylanthracene-2,6-diyl)dipiperidine, 1,1'-(9,10-di(naphthalen-2-yl)anthracene-2,6-diyl)dipiperidine, 1,1'-(9-(2-(naphthalen-1-yl)phenyl)-10-phenylanthracene-2,6-diyl)bis(1,2,3,4-tetrahydroquinoline), and 1,1',1'',1'''-(9,10-di(naphthalen-2-yl)anthracene-2,3,6,7-tetrayl)tetrakis(1,2,3,4-tetrahydroquinoline).    EXAMPLE - In a reaction vessel, 2,6-dibromo-9,10-di-naphthalen-2-yl-anthracene (4 g), iminodibenzyl (3.3 g), Pd(OAc)2 (0.07 g), P(tert-Bu)3 (50% in toluene) (0.3 ml), Cs2CO3 (6.6 g) and toluene (50 ml) were stirred at 110 degrees C for 5 hours. After adding methanol (50 ml), the solid produced was filtered under reduced pressure, and washed with distilled water, methanol and hexane. The solid was mixed with ethyl acetate (100 ml), and stirred under reflux for 2 hours. After filtering under reduced pressure, the solid was purified via column chromatography. The solid obtained was dissolved in tetrahydrofuran, and the mixture was added to methanol. Filtration under reduced pressure gave 5,5'-(9,10-di(naphthalen-2-yl)anthracene-2,6-diyl)bis(10,11-dihydro-5H-dibenzo(b,f)azepine) (1.6 g, 1.95 mmol).